Nuveen Asset Management, LLC Icad Inc Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.02 - $4.56 $207,984 - $314,042	-68,869 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.7 - $11.38 $52,487 - $89,150	-7,834 Reduced 10.21%	68,869 $448,000
Q3 2021 Nov 12, 2021	BUY	$10.11 - $17.56 $10,069 - $17,489	996 Added 1.32%	76,703 $801,000
Q2 2021 Aug 16, 2021	BUY	$14.9 - $20.82 $129,793 - $181,363	8,711 Added 13.0%	75,707 $1.31 Million
Q1 2021 May 17, 2021	SELL	$12.57 - $21.22 $54,252 - $91,585	-4,316 Reduced 6.05%	66,996 $1.42 Million
Q4 2020 Feb 16, 2021	BUY	$8.73 - $14.56 $6,364 - $10,614	729 Added 1.03%	71,312 $941,000
Q3 2020 Nov 16, 2020	BUY	$8.56 - $11.6 $2,987 - $4,048	349 Added 0.5%	70,583 $622,000
Q2 2020 Aug 14, 2020	BUY	$6.63 - $12.85 $465,651 - $902,506	70,234 New	70,234 $702,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $40M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.